SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 3rd, 2016 • Immune Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of July 29, 2016, between Immune Pharmaceuticals Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
COMMON STOCK PURCHASE WARRANT IMMUNE PHARMACEUTICALS inc.Immune Pharmaceuticals Inc • August 3rd, 2016 • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _________ (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after July 28, 2016 (the “Initial Exercise Date”) and on or prior to 5:00 p.m. NY Standard Time on July 28, 2021, the five-year anniversary of the Issuance Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Immune Pharmaceuticals Inc., a Delaware corporation (the “Company”), up to _______ shares (the “Warrant Shares”) of Common Stock, par value $0.0001 per share of the Company. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 1 hereunder.
